Collectively, the foregoing bioinformatic analyses indicated that SIRT1 might be implicated in the metabolic conversion of glucolipids and augment the metabolic flexibility of tumor cells by promoting FAO while inhibiting glycolysis. This evidence concerns the gene SIRT1 and neoplasm.